Collplant appoints additive manufacturing executive, hugh evans to its board of directors

Rehovot, israel, march 29, 2021 /prnewswire/ -- collplant (nasdaq: clgn), a regenerative and aesthetics medicine company, today announced the appointment of hugh evans to its board of directors, increasing the board to six independent members. u.s.-based mr.

CLGN Ratings Summary

CLGN Quant Ranking